Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2007
03/21/2007CN1931201A Subing spray and its prepn process
03/21/2007CN1931193A Medicine for treating various types of noxious sore, angiitis and stomatocace
03/21/2007CN1931183A Functional sea food for lowering blood pressure
03/21/2007CN1931182A Health food for preventing and treating cardiac and cerebral vascular diseases and its production process
03/21/2007CN1931180A Medicines of different characters and their prepn and use
03/21/2007CN1931179A Medicine composition and its prepn process
03/21/2007CN1931176A Aescin medicine composition and its prepn process and use
03/21/2007CN1931174A Aspirin buccal tablet and its prepn process
03/21/2007CN1931167A Double layer osmotic pump controlled release felodipine medicine composition
03/21/2007CN1931166A Hypertension treating medicine
03/21/2007CN1931161A Slow released indapamide microcapsule and its prepn process
03/21/2007CN1931160A Ginkgo ketone ester dropping pill and its prepn process
03/21/2007CN1931143A Orally taken control released trimetazidine medicine composition
03/21/2007CN1931142A Slow released cilostazol prepn and its prepn process
03/21/2007CN1931141A Carvedilol dripping pill and its prepn process
03/21/2007CN1931133A Total arasaponin precursor liposome and its prepn process
03/21/2007CN1931131A Oil-in-water type nanometer peonol emulsion oral liquid and its prepn process
03/21/2007CN1931056A Blood pressure lowering pillow
03/21/2007CN1306020C Polyporus frondosus oral liquor and its production method
03/21/2007CN1305894C Process for extracting total saponin of American ginseng and powder injection thereof
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/21/2007CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands
03/21/2007CN1305856C New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
03/21/2007CN1305853C Process for the manufacture of HMG-coa reductase inhibitors
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305839C Phenylglycine derivatives
03/21/2007CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries
03/21/2007CN1305493C Chinese medicine effective part for treating cerebral apoplexy and its separation preparing process
03/21/2007CN1305485C Injection danhong and its preparing method
03/21/2007CN1305482C Medicine for curing pile and its preparing method
03/21/2007CN1305481C Preparation of moschus for refreshment
03/21/2007CN1305474C Nose cavity administering formulation of nalmefene
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192959 Sodium channel blockers
03/20/2007US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
03/20/2007US7192946 Hyperlipemia agents; bile acid transport inhibitors
03/20/2007US7192945 Benzothiazepine derivatives
03/20/2007US7192940 Ether compounds
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192922 Method of treating left ventricular dysfunction
03/20/2007US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
03/20/2007US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
03/20/2007US7192616 Slow down or even inhibit cellular differentiation and/or proliferation.
03/20/2007US7192613 Allium sativum bulb absolutes and therapeutic or cosmetic uses
03/20/2007US7192570 Compositions of somatostatin analogues
03/15/2007WO2007029889A1 Protective action of serofendic acid on cardiac muscle
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029781A1 Adhesive preparation containing bisoprolol
03/15/2007WO2007029773A1 Cholesterol absorption inhibitor
03/15/2007WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
03/15/2007WO2007029255A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients
03/15/2007WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds
03/15/2007WO2007013078A3 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology
03/15/2007WO2007010312A3 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect
03/15/2007WO2006131884A3 Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors
03/15/2007WO2006060127A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
03/15/2007WO2006021942A3 Platelet modulating oligopeptides
03/15/2007WO2005063745A8 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
03/15/2007US20070061921 Transgenic cells
03/15/2007US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
03/15/2007US20070060647 Gene expression regulating agent
03/15/2007US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060568 5HT2c receptor modulators
03/15/2007US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto
03/15/2007US20070060531 Pyrazole derivative, drug composition containing the same and production intermediate therefor
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
03/15/2007US20070059357 Adiponectin production enhancer
03/15/2007US20070059338 Compositions and techniques for localized therapy
03/15/2007US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer
03/15/2007US20070059305 Neutralizing human anti-IGFR antibody
03/15/2007US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent
03/15/2007DE202007000338U1 Zusammensetzung zur Vorbeugung und Behandlung von Gefäßverschlusserkrankungen Composition for the prevention and treatment of vascular occlusive diseases
03/15/2007DE102005017605B4 Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 2-aminoalkylthio-benzimidazoles, process for their preparation and their use as medicaments
03/15/2007CA2621582A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients
03/15/2007CA2621470A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/14/2007EP1762623A1 Methods for producing biologically active peptide dimers
03/14/2007EP1762610A1 Truncated dance, dance complex and method of using these
03/14/2007EP1762568A1 Pyrazole derivatives
03/14/2007EP1762558A1 Process for preparing transcription factors and their use
03/14/2007EP1762557A2 Aspirin-triggered lipid mediators
03/14/2007EP1761560A1 Peptide-based compounds
03/14/2007EP1761522A1 Compounds and methods for treating dyslipidemia
03/14/2007EP1761521A1 Compounds and methods for treating dyslipidemia
03/14/2007EP1761485A1 Amidino compounds as cysteine protease inhibitors
03/14/2007EP1761482A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides
03/14/2007EP1761310A1 Drug eluting implants to prevent cardiac apoptosis